Unknown

Dataset Information

Low-dose naltrexone is effective and well-tolerated for modulating symptoms in patients with neuropathic corneal pain.


ABSTRACT:

Purpose

Neuropathic corneal pain (NCP) is caused by damage or disease of the somatosensory nervous system that innervates the cornea and presents with symptoms of pain or persistent unpleasant sensations, such as burning, dryness, or light sensitivity. This retrospective study aims to assess the efficacy and tolerability of low-dose naltrexone (LDN) in refractory NCP patients.

Methods

Fifty-nine NCP patients with a centralized component treated with oral LDN 4.5  mg at bedtime for at least four weeks were identified. Thirty out of 59 patients who had a baseline pain score ≥4 on the visual analogue scale had completed the ocular pain assessment survey (OPAS) and presented persistent pain, despite instillation of topical anesthetic drops, were included. Changes in pain scores,

SUBMITTER: Dieckmann G 

PROVIDER: S-EPMC9009761 | biostudies-literature | 2021 Apr

REPOSITORIES: biostudies-literature